|
|
||||||||
B1
Department of Psychiatry, University of Freiburg Medical School, Freiburg, Germany
Substance P (SP), a member of the tachykinin peptide family, is a
major mediator of neuroimmunomodulatory activities and neurogenic
inflammation within the central and peripheral nervous system. SP has
been shown to induce the expression of proinflammatory cytokines such
as IL-6, which might be implicated in the etiopathology of several
human brain disorders. We showed in a previous study that nanomolar
concentrations of SP triggered activation of NF-
B, a transcription
factor involved in the control of cytokine expression. However,
activation of NF-
B was not involved in SP-induced expression of
IL-6. Here, we describe p38 mitogen-activated protein kinase (p38 MAPK)
as a signal transduction component that operates independently from
NF-
B activation and that mediates SP-induced IL-6 expression in the
human astrocytoma cell line U373 MG. SP induced the phosphorylation of
p38 MAPK within 10 min, and this activation persisted up to 30 min and
was independent from p42/44 MAPKs and protein kinase C activation,
which all are induced after stimulation with SP. As shown by EMSA, p38
MAPK was not involved in SP-induced activation of NF-
B. p38 MAPK,
however, mediated SP-induced IL-6 expression as shown by the use of
specific inhibitors of this kinase. Our results suggest that activation
of p38 MAPK is an important component controlling neurogenic
inflammation within the CNS independently from NF-
B. Drugs targeting
this MAPK may therefore interfere with SP-correlated neuropsychiatric
disorders and may represent a therapeutic approach in these
disorders.
This article has been cited by other articles:
![]() |
V. S. Chauhan, D. G. Sterka Jr., D. L. Gray, K. L. Bost, and I. Marriott Neurogenic Exacerbation of Microglial and Astrocyte Responses to Neisseria meningitidis and Borrelia burgdorferi J. Immunol., June 15, 2008; 180(12): 8241 - 8249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, R. D. Ramnath, L. Zhi, R. Tamizhselvi, and M. Bhatia Substance P enhances NF-{kappa}B transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1586 - C1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pantenburg, S. M. Dann, H.-C. Wang, P. Robinson, A. Castellanos-Gonzalez, D. E. Lewis, and A. C. White Jr. Intestinal Immune Response to Human Cryptosporidium sp. Infection Infect. Immun., January 1, 2008; 76(1): 23 - 29. [Full Text] [PDF] |
||||
![]() |
J. Sun, R. D. Ramnath, and M. Bhatia Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils Am J Physiol Cell Physiol, August 1, 2007; 293(2): C696 - C704. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Koon, D. Zhao, Y. Zhan, S. H. Rhee, M. P. Moyer, and C. Pothoulakis Substance P Stimulates Cyclooxygenase-2 and Prostaglandin E2 Expression through JAK-STAT Activation in Human Colonic Epithelial Cells. J. Immunol., April 15, 2006; 176(8): 5050 - 5059. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Karagiannides, E. Kokkotou, M. Tansky, T. Tchkonia, N. Giorgadze, M. O'Brien, S. E. Leeman, J. L. Kirkland, and C. Pothoulakis Induction of colitis causes inflammatory responses in fat depots: Evidence for substance P pathways in human mesenteric preadipocytes PNAS, March 28, 2006; 103(13): 5207 - 5212. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Koon, D. Zhao, Y. Zhan, S. Simeonidis, M. P. Moyer, and C. Pothoulakis Substance P-Stimulated Interleukin-8 Expression in Human Colonic Epithelial Cells Involves Protein Kinase C{delta} Activation J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1393 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Koon, D. Zhao, X. Na, M. P. Moyer, and C. Pothoulakis Metalloproteinases and Transforming Growth Factor-{alpha} Mediate Substance P-induced Mitogen-activated Protein Kinase Activation and Proliferation in Human Colonocytes J. Biol. Chem., October 29, 2004; 279(44): 45519 - 45527. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lin, D. K. Crockett, S. D. Jenson, M. S. Lim, and K. S. J. Elenitoba-Johnson Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells Mol. Cell. Proteomics, August 1, 2004; 3(8): 820 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zimmer, M. Rohn, G. P. McGregor, M. Schemann, K.-K. Conzelmann, and G. Herrler Virokinin, a Bioactive Peptide of the Tachykinin Family, Is Released from the Fusion Protein of Bovine Respiratory Syncytial Virus J. Biol. Chem., November 21, 2003; 278(47): 46854 - 46861. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson Curcumin attenuates DNB-induced murine colitis Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G235 - G243. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Simeonidis, I. Castagliuolo, A. Pan, J. Liu, C.-C. Wang, A. Mykoniatis, A. Pasha, L. Valenick, S. Sougioultzis, D. Zhao, et al. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter PNAS, March 4, 2003; 100(5): 2957 - 2962. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Morris, R. D. Lutz, H.-S. Choi, T. Kamitani, K. Chmura, and E. D. Chan Role of the NF-{kappa}B Signaling Pathway and {kappa}B cis-Regulatory Elements on the IRF-1 and iNOS Promoter Regions in Mycobacterial Lipoarabinomannan Induction of Nitric Oxide Infect. Immun., March 1, 2003; 71(3): 1442 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Saban, N. P. Gerard, M. R. Saban, N.-B. Nguyen, D. J. DeBoer, and B. K. Wershil Mast cells mediate substance P-induced bladder inflammation through an NK1 receptor-independent mechanism Am J Physiol Renal Physiol, October 1, 2002; 283(4): F616 - F629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |